Industry: Pharmaceuticals, Biotechnology
Inspiration Biopharmaceuticals, Inc. was founded in 2004 by two dedicated fathers of children with hemophilia. Its focus is to revolutionize treatment of hemophilia through production of lower cost versions of existing intravenous recombinant therapies and development of non-invasive applications to enhance prophylactic administration. It is estimated that only 25% of hemophilia patients worldwide receive treatment. Today, the average cost of hemophilia therapy for an adult has risen to nearly $200,000 per year while the average annual cost for a child exceeds $100,000. Current therapies for the treatment of hemophilia are expensive to produce and are only effective when injected ( www.inspirationbio.com )
Inspiration Biopharmaceuticals Inc
28202 Cabot Road Suite 300
Lauguna Niguel, California 92677
USA
Tel: (888) 808-0896